Reported 2 days ago
Pfizer Inc. (PFE) has faced a decline in stock value over the past decade but shows promise with a robust pipeline of drugs and a strong balance sheet. Despite mixed earnings for Q1 2025, with revenue dropping 8% year-over-year, the company beat EPS expectations and continues to prioritize shareholder returns, having raised dividends for 15 consecutive years. Currently, it offers a quarterly dividend of $0.43 per share, reflecting a yield of 7.03%. However, some analysts suggest that certain AI stocks may present more attractive investment opportunities.
Source: YAHOO